Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1973 1
1975 1
1977 1
1988 1
1991 2
1993 2
1994 2
1996 2
1997 1
1998 1
1999 1
2000 2
2001 2
2002 2
2003 4
2004 3
2005 7
2006 11
2007 11
2008 14
2009 21
2010 20
2011 22
2012 28
2013 27
2014 25
2015 21
2016 22
2017 22
2018 19
2019 17
2020 33
2021 20
2022 29
2023 25
2024 31
2025 12

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

414 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of Butantan-DV in participants aged 2-59 years through an extended follow-up: results from a double-blind, randomised, placebo-controlled, phase 3, multicentre trial in Brazil.
Nogueira ML, Cintra MAT, Moreira JA, Patiño EG, Braga PE, Tenório JCV, de Oliveira Alves LB, Infante V, Silveira DHR, de Lacerda MVG, Pereira DB, da Fonseca AJ, Gurgel RQ, Coelho IC, Fontes CJF, Marques ETA, Romero GAS, Teixeira MM, Siqueira AM, Boaventura VS, Ramos F, Júnior EE, de Moraes JC, Whitehead SS, Esteves-Jaramillo A, Shekar T, Lee JJ, Macey J, Kelner SG, Coller BG, Boulos FC, Kallás EG; Phase 3 Butantan-DV Working Group. Nogueira ML, et al. Lancet Infect Dis. 2024 Nov;24(11):1234-1244. doi: 10.1016/S1473-3099(24)00376-1. Epub 2024 Aug 5. Lancet Infect Dis. 2024. PMID: 39116904 Clinical Trial.
Development of synthetic antigen vaccines for COVID-19.
Viana Invenção MDC, Melo ARDS, de Macêdo LS, da Costa Neves TSP, de Melo CML, Cordeiro MN, de Aragão Batista MV, de Freitas AC. Viana Invenção MDC, et al. Among authors: de freitas ac. Hum Vaccin Immunother. 2021 Nov 2;17(11):3855-3870. doi: 10.1080/21645515.2021.1974288. Epub 2021 Oct 6. Hum Vaccin Immunother. 2021. PMID: 34613880 Free PMC article. Review.
A postsynaptic GPR158-PLCXD2 complex controls spine apparatus abundance and dendritic spine maturation.
Verpoort B, Amado L, Vandensteen J, Leysen E, Dascenco D, Vandenbempt J, Lemmens I, Wauman J, Vennekens K, Escamilla-Ayala A, Freitas ACN, Voets T, Munck S, Tavernier J, Wierda K, de Wit J. Verpoort B, et al. Among authors: freitas acn. Dev Cell. 2025 May 16:S1534-5807(25)00263-1. doi: 10.1016/j.devcel.2025.04.025. Online ahead of print. Dev Cell. 2025. PMID: 40393451
Goldenhar's syndrome--case report.
Pinheiro AL, Araújo LC, Oliveira SB, Sampaio MC, Freitas AC. Pinheiro AL, et al. Among authors: freitas ac. Braz Dent J. 2003;14(1):67-70. doi: 10.1590/s0103-64402003000100013. Epub 2003 Jul 31. Braz Dent J. 2003. PMID: 12656469 Free article.
RNA Vaccines: Yeast as a Novel Antigen Vehicle.
Silva AJD, de Sousa MMG, de Macêdo LS, de França Neto PL, de Moura IA, Espinoza BCF, Invenção MDCV, de Pinho SS, da Gama MATM, de Freitas AC. Silva AJD, et al. Among authors: de freitas ac. Vaccines (Basel). 2023 Aug 7;11(8):1334. doi: 10.3390/vaccines11081334. Vaccines (Basel). 2023. PMID: 37631902 Free PMC article. Review.
Human papillomavirus and lung cancinogenesis: an overview.
de Freitas AC, Gurgel AP, de Lima EG, de França São Marcos B, do Amaral CM. de Freitas AC, et al. J Cancer Res Clin Oncol. 2016 Dec;142(12):2415-2427. doi: 10.1007/s00432-016-2197-1. Epub 2016 Jun 29. J Cancer Res Clin Oncol. 2016. PMID: 27357515 Free PMC article. Review.
Current research into novel therapeutic vaccines against cervical cancer.
Cordeiro MN, De Lima RCP, Paolini F, Melo ARDS, Campos APF, Venuti A, De Freitas AC. Cordeiro MN, et al. Among authors: de freitas ac. Expert Rev Anticancer Ther. 2018 Apr;18(4):365-376. doi: 10.1080/14737140.2018.1445527. Epub 2018 Mar 13. Expert Rev Anticancer Ther. 2018. PMID: 29475377 Review.
Perspectives of topical formulations for melasma.
de Freitas ACP, Rigon RB, Bagatin E, Leonardi GR. de Freitas ACP, et al. Int J Dermatol. 2023 Feb;62(2):260-268. doi: 10.1111/ijd.16421. Epub 2022 Sep 9. Int J Dermatol. 2023. PMID: 36083295
Evolving trends in next-generation probiotics: a 5W1H perspective.
Almeida D, Machado D, Andrade JC, Mendo S, Gomes AM, Freitas AC. Almeida D, et al. Among authors: freitas ac. Crit Rev Food Sci Nutr. 2020;60(11):1783-1796. doi: 10.1080/10408398.2019.1599812. Epub 2019 May 7. Crit Rev Food Sci Nutr. 2020. PMID: 31062600 Review.
414 results